7.1.2.2.5FCA_ILearning Outcome
Advantages, disadvantages, indications and contraindications of high-flow nasal oxygen (HFNO), non-invasive and invasive positive pressure ventilation
lines 817–818id: LO_7.1.2.2_5_FCA_I
10 items
- 7.1.2.2_5.1FCA_IVentilation strategies and non-ventilator therapies to optimise oxygenation and ventilation and minimise lung injury
- 7.1.2.2_5.2FCA_IInitiation of non-invasive ventilation (NIV) and management of patients receiving NIV in the intensive care setting
- 7.1.2.2_5.3FCA_IRoles and selection of different modes of ventilation, including but not limited to continuous mandatory ventilation, volume control modes, pressure control modes, synchronised intermittent mandatory ventilation, pressure support, *inverse ratio ventilation, continuous positive airway pressure (CPAP), bilevel/airway pressure release ventilation and high-frequency oscillation
- 7.1.2.2_5.4FCA_IComplications of ventilation and the strategies to minimise ventilator-induced lung injury, including the ventilation of acute respiratory distress syndrome (ARDS) patients
- 7.1.2.2_5.5FCA_IHaemodynamic effects of positive pressure ventilation (heart-lung interactions)
- 7.1.2.2_5.6FCA_IPathophysiology of and approach to the management of patient-ventilator dyssynchrony
- 7.1.2.2_5.7FCA_IInterpret and use blood gas analysis to guide respiratory support
- 7.1.2.2_5.8FCA_IVentilator graphics (pressure, flow, volume, loops)
- 7.1.2.2_5.9FCA_IDecisions to wean ventilation, strategies for weaning patients from ventilator support and assessment of success
- 7.1.2.2_5.10FCA_IDeliberate indications for the use of extracorporeal membrane oxygenation (ECMO) in respiratory failure and the principles of its delivery